Insider · CIK 0001817988

ALTSCHULLER Susan

Reports to the SEC for 4 companies · WELLESLEY HILLS, MA

sec.gov

Transactions

Companies

Filings

CIK

0001817988

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-06	CLYMClimb Bio, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+143K sh	—	—	142,500
2025-10-01	CLYMClimb Bio, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+600K sh	—	—	600,000
2024-08-14	Mural Oncology plcP Purchase	Director	PPurchase	+10K sh	$3.21	+$32.1K	10,000
2024-08-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−124K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−16.9K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−81.1K sh	—	—	0
2024-05-30	Mural Oncology plcStock Option (right to buy)A Award	Director	AAward	+8,462 sh	—	—	8,462
2024-05-30	Mural Oncology plcStock Option (right to buy)A Award	Director	AAward	+8,462 sh	$3.35	+$28.3K	8,462
2024-01-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+81.1K sh	—	—	81,065
2023-12-20	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Financial Officer	SSale	−13.8K sh	$41.42	−$572K	16,913
2023-12-19	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+30.7K sh	—	—	30,721
2023-12-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−30.7K sh	—	—	0
2023-12-14	Mural Oncology plcStock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,021
2023-06-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+30.7K sh	—	—	30,721
2023-06-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+124K sh	—	—	124,168
2022-11-14	ImmunoGen, Inc.Stock Option (Right to Buy)A Award	SVP AND CFO	AAward	+82.5K sh	—	—	123,750
2022-05-20	ImmunoGen, Inc.Stock Option (Right to Buy)A Award	SVP AND CFO	AAward	+41.3K sh	—	—	41,250
2022-02-04	ImmunoGen, Inc.Common Stock (right to buy)A Award	SVP AND CFO	AAward	+362K sh	$5.32	+$1.92M	361,568
2021-02-05	ImmunoGen, Inc.Common Stock (right to buy)A Award	SVP AND CFO	AAward	+164K sh	$7.69	+$1.26M	163,798
2020-07-20	ImmunoGen, Inc.Common Stock (right to buy)A Award	SVP AND CFO	AAward	+300K sh	$4.74	+$1.42M	300,000

Recent filings

Accepted (ET)
Jan 84
ALTSCHULLER Susan0001193125-26-007665
SEC(opens sec.gov)
Oct 14
ALTSCHULLER Susan0001193125-25-227099
SEC(opens sec.gov)
Aug 154
ALTSCHULLER Susan0000950170-24-097576
SEC(opens sec.gov)
Aug 54
ALTSCHULLER Susan0000950170-24-090813
SEC(opens sec.gov)
Jun 54/A
ALTSCHULLER Susan0000950170-24-069301
SEC(opens sec.gov)
Jun 34
ALTSCHULLER Susan0000950170-24-067702
SEC(opens sec.gov)
Jan 234
ALTSCHULLER Susan0000950170-24-006706
SEC(opens sec.gov)
Dec 214
ALTSCHULLER Susan0000950170-23-072368
SEC(opens sec.gov)
Dec 184
ALTSCHULLER Susan0000950170-23-071107
SEC(opens sec.gov)
Jun 54
ALTSCHULLER Susan0000950170-23-026503
SEC(opens sec.gov)
Dec 274
ALTSCHULLER Susan0001415889-22-012991
SEC(opens sec.gov)
Feb 84
ALTSCHULLER Susan0001179110-22-000926
SEC(opens sec.gov)
Feb 94
ALTSCHULLER Susan0001179110-21-001496
SEC(opens sec.gov)
Jul 224
ALTSCHULLER Susan0001179110-20-008407
SEC(opens sec.gov)

Companies

Address

C/O CLIMB BIO, INC. 20 WILLIAM STREET, SUITE 145

WELLESLEY HILLS, MA, 02481